OR WAIT null SECS
Assistant Professor of Medicine
Director of Education and Training
Rheumatology Director, Yale Lupus Program
Yale School of Medicine
March 18, 2022
Video
The rationale for using a newer monoclonal antibody therapy, anifrolumab, to manage patients with systemic lupus erythematosus.